DoH and MIT- Koch Institute Partner to Advance AI-Driven Cancer Research
ABU DHABI, UAE, July 3, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the...
Cancer
Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026
ORION CORPORATION PRESS RELEASE 3 JULY 2026 at 9.00 EEST Orion publishes Half-Year Report for January–June 2026 and holds a...
Fundamentals of Radiation Oncology, 4th Edition Receives Highly Favorable Review from Chief of NIH/NCI Radiation Oncology Branch
PANAMA CITY, Fla., July 2, 2026 /PRNewswire/ -- Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition, edited...
ASCO 2026: Turn Oncology Data into Smarter Trial Strategy, Upcoming Webinar Hosted by Xtalks
In this free webinar, oncology experts will discuss what ASCO 2026 data could mean for cancer clinical trials and patient...
Cornerstone Physiotherapy Marks 18 Years With Milestone Opening of 10th GTA Location
TORONTO, ON / ACCESS Newswire / July 2, 2026 / Cornerstone Physiotherapy, a multidisciplinary clinical group founded in 2008 by...
Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC
Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - July 2, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC
Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - July 2, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3)...
HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification
First selective MET inhibitor approved for patients with MET-amplified advanced gastric cancer or gastroesophageal junction adenocarcinoma in ChinaHONG KONG and...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed...
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company...
FDA Alignment to Advance ProstACT Global Phase 3 Trial
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States.FDA...
Junshi Biosciences Enters Licensing Collaboration with Fosun Wanbang on Roconkibart (IL-17A)
SHANGHAI, July 01, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading...
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEEDHAM, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical...
Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing...
BIOSAPIEN – THE REVOLUTIONARY CANCER PLATFORM DEVELOPER – ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
SAN DIEGO, July 1, 2026 /PRNewswire/ -- BioSapien, the pioneering biotech company, announces two world-class US manufacturing partners, ahead of...
BIOSAPIEN – THE REVOLUTIONARY CANCER PLATFORM DEVELOPER – ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
SAN DIEGO, July 1, 2026 /PRNewswire/ -- BioSapien, the pioneering biotech company, announces two world-class US manufacturing partners, ahead of...
Caris Life Sciences Launches Caris Detect, the World’s Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
Ultra-deep Whole Genome and Whole Transcriptome sequencing combined with sophisticated AI algorithmsdelivers superior performance to existing cancer detection technologiesIRVING, Texas,...
Oncologists Say Cancer Care Starts Too Late – PreOncology™ Launches New Medical Specialty Focused on Finding Cancer Before Stage I
New prevention-focused model combines genomics, AI-powered risk assessment, personalized surveillance, and oncologist-led clinical review to identify cancer at its earliest...
Caris Life Sciences Launches Caris Detect, the World’s Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test
Ultra-deep Whole Genome and Whole Transcriptome sequencing combined with sophisticated AI algorithmsdelivers superior performance to existing cancer detection technologiesIRVING, Texas,...
Oncologists Say Cancer Care Starts Too Late – PreOncology™ Launches New Medical Specialty Focused on Finding Cancer Before Stage I
New prevention-focused model combines genomics, AI-powered risk assessment, personalized surveillance, and oncologist-led clinical review to identify cancer at its earliest...